about
Current status of cranial stereotactic radiosurgery in the UKVolumetric modulated arc therapy: a review of current literature and clinical use in practice.Radiation therapy quality assurance in clinical trials--Global Harmonisation GroupImplementation of IMRT in the radiotherapy department.A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes.Inter-departmental dosimetry audits - development of methods and lessons learned.Feasibility of using glass-bead thermoluminescent dosimeters for radiotherapy treatment plan verification.Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.Development of a novel treatment planning test for credentialing rotational intensity-modulated radiotherapy techniques in the UK.The role of complexity metrics in a multi-institutional dosimetry audit of VMAT.The use of log file analysis within VMAT audits.Challenges in calculation of the gamma index in radiotherapy - Towards good practice.Changes in Patterns of Intensity-modulated Radiotherapy Verification and Quality Assurance in the UK.The role of dosimetry audit in lung SBRT multi-centre clinical trials.Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.A methodology for dosimetry audit of rotational radiotherapy using a commercial detector array.Dose-response analysis of parotid gland function: what is the best measure of xerostomia?Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers.Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.1st European Congress of Medical Physics September 1-4, 2016; Medical Physics innovation and vision within Europe and beyond.A virtual dosimetry audit - Towards transferability of gamma index analysis between clinical trial QA groups.A national dosimetry audit for stereotactic ablative radiotherapy in lung.Adaptation and validation of a commercial head phantom for cranial radiosurgery dosimetry end-to-end audit.Expanding the scientific role of medical physics in radiotherapy: Time to act.A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification.The use of electronic portal imaging to verify patient position during intensity-modulated radiotherapy delivered by the dynamic MLC technique.Evaluation of Gafchromic EBT-XD film, with comparison to EBT3 film, and application in high dose radiotherapy verification.A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy.Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trialIn regard to Lee et al., IJROBP 2002;53:630-637Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynxTarget volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelinesIntensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary siteA phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancerVerification of patient position and delivery of IMRT by electronic portal imagingIntensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I studyDose to bone marrow using IMRT techniques in prostate cancer patientsThe impact of introducing intensity modulated radiotherapy into routine clinical practiceDose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers
P50
Q30364393-779DD87D-0782-4E77-87CC-429DA77A22E7Q30461426-4E4AE113-3A35-405E-8FD6-324B584AA5E7Q34815954-764F64F8-AA93-490E-935C-4C17D0749619Q35623587-0AF61C48-8051-4A95-AC55-D9188CAA01EFQ35677705-E39C83D2-4BB1-404C-9751-4D0BA6697519Q36508168-467CFAE3-49A5-4814-94B0-1315608BE325Q36550506-86E22ECE-246A-42B5-92A9-3E8B7EFA0F1CQ36550547-6502B67B-8558-44D6-8266-CC4D0AF574F8Q36715968-E4F7AEC9-FC1A-4A38-BDD4-90C09EE18705Q37177835-FAFD8727-FB33-4366-9889-411478988398Q37601056-189CBF42-213C-470D-B1B6-C7C0A861FB5FQ38836498-897C1A48-CCAA-461D-8700-20D8C6B64B43Q38907887-AEE2F752-B969-464D-BC6B-56B04AD4C628Q39229812-0B67780F-C3D9-4909-84CB-C5E31295BDF2Q39571161-AD1AF794-626C-4688-8955-A3CE418E3B3EQ43723611-C3F6E2AB-9A26-4D3D-B333-D299E8A39C8DQ44011115-A0758183-82FE-428A-AF7A-9B50D20FFF14Q44120266-224CBFF3-A588-4DC9-9733-3A3935DE592AQ44745177-EE61BAF8-0493-4031-8969-05936E59F516Q45007224-2FA090DB-11AE-4A5F-917D-D5DA2D54F025Q45063329-D24A459C-F05F-4DAF-821A-6271BCAFB636Q47662085-3A44FFD1-7F2C-4582-8FD5-B10A7FE4CF14Q47997714-1E7F3CB0-822A-4681-8DD1-7B3B3D11BBD7Q48219011-2519233E-E4AB-4B90-B7AC-C099867FDDC9Q50542952-425BF0BF-F59E-48D1-B836-5BFD998CD817Q51139823-90370D17-793B-40DF-9619-0741AE0D8CC0Q51640377-B28D9057-D0F8-4F5A-A769-D813D372587DQ51667407-A01FD39A-5CE0-4837-8E20-0D6DE679DFF1Q53371465-92C339DD-F8DD-4A51-8C11-D93C74D3DE53Q57539336-AA8A4216-A0A0-4309-BC58-48D1F6C35CE5Q73047888-BFCE2F1A-FF1D-42B4-9487-184629F6B964Q79792680-2AE5946A-DECF-4971-8246-9EE847F4C1E5Q80812187-0681CE95-DE99-481B-8691-647507477548Q80813870-33B71A9D-2473-4925-90AC-4ED685D80805Q80818700-4B8B6D0D-25FB-4201-8E52-2009149AE7C4Q81119401-E8EFBDBE-402C-4430-95F1-1F03B90DA319Q81371340-9250F204-5BAC-44FA-821E-1D94AD8770F0Q81499427-BCD31610-CAEF-4CAA-A939-53B092B56970Q81504561-5613F370-4E01-467D-9976-983B6E5B8BF6Q83209504-A6354B9E-71ED-491C-A4A3-E4E626702491
P50
description
researcher
@en
wetenschapper
@nl
name
Catharine H Clark
@en
Catharine H Clark
@nl
type
label
Catharine H Clark
@en
Catharine H Clark
@nl
prefLabel
Catharine H Clark
@en
Catharine H Clark
@nl
P106
P31
P496
0000-0003-2287-8212